Copyright © 2019 myCBDauthority – All rights reserved. Your use of this site is governed by our Medical Disclaimer and Privacy Policy. myCBDauthority does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. myCBDauthority reviews third-party products independently, and therefore some articles may contain affiliate links.
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.
Because CBD oil products are mostly unregulated, there’s no guarantee that any given product contains a safe or effective level of CBD. In fact, a study published in the Journal of the American Medical Association in 2017 found that nearly 70 percent of all CBD products sold online are incorrectly labeled, and could cause serious harm to consumers. Some CBD oils may also contain incorrectly labeled amounts of THC and other compounds.
According to the largest study to date, researchers reported that after treating 162 patients with an extract of 99% cannabidiol (CBD), for a 12 week period. the intervention reduced motor seizures at a rate similar to existing drugs ( a median of 36.5 percent) and 2% of patients became completely seizure free. Other studies have shown that it can act as an anticonvulsant.

Due to the anti-inflammatory properties of cannabidiol, insulin resistance (the chief metabolic problem for patients with type 2 diabetes) is reduced, leading to a better prognosis thanks also to the lower incidence of dead tissue. Ever since the discovery of CBD in the 1990’s, speculation existed to its effect on other types of receptors (not just cannabinoid receptors) which could be manipulated and included in the treatment of some cardiovascular diseases like atherosclerosis. In light of these speculations, researchers at the University of Tel Aviv (walking in the footsteps of the “father” of cannabinoid research, Dr. Raphael Mechoulam) demonstrated a 30 percent blood flow increase in rodents with areas of dead tissue in the heart muscle.[22]
Unlike THC, the psychoactive compound which is responsible for giving you that high effect, CBD, is non-psychoactive and a proven aid for nausea, pain, and anxiety (plus, if extracted from industrial hemp, it’s legal). CBD is also known to be anti-inflammatory, analgesic, antispasmodic, cell-regenerative, and anti–cell proliferative for bad cells. This means that CBD is a potential therapy for a range of medical conditions.
×